Alborz Zagros

Alborz Zagros Pharmaceutical is a prominent Iranian pharmaceutical company dedicated to the manufacturing and distribution of generic medicinal products. Established in 2013, the company operates a state-of-the-art production facility in the Alborz Industrial City, focusing on solid dosage forms such as tablets and capsules. Its product portfolio spans critical therapeutic categories, including cardiovascular health, metabolic disorders, and anti-infectives. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), Alborz Zagros plays a vital role in the Iranian healthcare supply chain by ensuring the availability of affordable, high-quality generic drugs. The company adheres to international Good Manufacturing Practice (GMP) standards to support both domestic consumption and regional export initiatives.